National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 2,281 cases where Vaccine is COVID19 and Symptom is COVID-19 and Patient Died



Case Details (Sorted by Age)

This is page 6 out of 229

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15   next


VAERS ID: 990314 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-01
Onset:2021-01-01
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL 1484 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Death, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-01
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ATORVASTATIN; FURIX [CEFUROXIME]; SOBRIL; METOPROLOL; LEVAXIN; WARAN; RAMIPRIL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Atrial fibrillation; Celiac disease; COVID-19; Ejection fraction low (35%); Heart failure; Hypothyroidism; Type II diabetes mellitus
Allergies:
Diagnostic Lab Data: Test Date: 202101; Test Name: COVID-19 virus test; Test Result: Positive
CDC Split Type: SEPFIZER INC2021067491

Write-up: Death; positive Covid-19 virus test after vaccination; positive Covid-19 virus test after vaccination; This is a spontaneous report from a contactable physician downloaded from the regulatory authority (SE-MPA-2021-000325 & SE-MPA-1610531706795). An 84-year-old female patient received bnt162b2 (COMIRNATY; Lot number: EL 1484), intramuscularly in Jan2021 at a single dose for COVID-19 immunization. Medical history included atrial fibrillation, Celiac disease, ejection fraction low (35%), type II diabetes mellitus, hypothyroidism, heart failure, COVID-19. Concomitant medication included atorvastatin (MANUFACTURER UNKNOWN), taken from 01Jan2017 to Jan2021, cefuroxime (FURIX), taken from 01Jan2017 to Jan2021, oxazepam (SOBRIL), taken from 01Jan2017 to Jan2021, metoprolol (MANUFACTURER UNKNOWN), taken from 01Jan2017 to Jan2021, levothyroxine sodium (LEVAXIN), taken from 01Jan2013 to Jan2021, warfarin sodium (WARAN), taken from 01Jan2011 to Jan2021 and ramipril (MANUFACTURER UNKNOWN) taken from 01Jan2013 to Jan2021. The patient had a positive Covid-19 virus test after vaccination and experienced death in Jan2021. The patient had no infection symptoms but tiredness days before vaccination. The patient was found dead, the day after vaccination with a suspected cerebro/cardiovascular event. The patient underwent lab tests and procedures which included COVID-19 virus test: positive in Jan2021. The outcome of positive Covid-19 virus test after vaccination was unknown. The patient died in Jan2021. It was not reported if an autopsy was performed. According to rapporteur, patient is not autopsied. Cerebro/cardiovascular event is only a suspicion based on patients medical history. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Unknown cause of death


VAERS ID: 993418 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-17
Onset:2021-01-05
   Days after vaccination:19
Submitted: 0000-00-00
Entered: 2021-02-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ0553 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-07
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Patient is not enrolled in clinical trial
Allergies:
Diagnostic Lab Data: Test Date: 20210105; Test Name: COVID-19 virus test; Test Result: Positive
CDC Split Type: GBPFIZER INC2021077026

Write-up: COVID-19 virus test positive; COVID-19 virus test positive; This is a spontaneous report received from a contactable other health professional via the Regulatory Authority. The Regulatory Authority report number is GB-MHRA-WEBCOVID-202101221706160690. Safety Report Unique Identifier GB-MHRA-ADR 24634077. An 87-year-old male patient received bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech, lot# EJ0553), via an unspecified route of administration, on 17Dec2020, at single dose, for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. Patient was not enrolled in clinical trial. The patient experienced COVID-19 virus test positive on 05Jan2021. The patient underwent lab tests and procedures which included COVID-19 virus test: positive on 05Jan2021. The infection was suspected from 03Jan2021. The patient died on 07Jan2021 due to COVID-19 virus test positive. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: COVID-19 virus test positive; COVID-19 virus test positive


VAERS ID: 993419 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-17
Onset:2020-12-26
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-02-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ0553 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, Lower respiratory tract infection, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-05
   Days after onset: 10
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Dementia; Parkinson''s disease
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20201226; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Yes - Positive COVID-19 test
CDC Split Type: GBPFIZER INC2021079551

Write-up: Lower respiratory tract infection; COVID-19; COVID-19; This is a spontaneous report from a contactable healthcare professional received from the RA. Regulatory authority report number GB-MHRA-WEBCOVID-202101221716105980, Safety Report Unique Identifier GB-MHRA-ADR 24634163. An 87-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number EJ0553) via an unspecified route of administration on 17Dec2020 at single dose for COVID-19 immunisation. Relevant medical history included ongoing Parkinson''s disease and ongoing dementia. Concomitant medications were not reported. The patient was not enrolled in clinical trial. On 26Dec2020, a COVID-19 virus test showed positive result and, on an unspecified date, he developed a lower respiratory tract infection (chest infection). The outcome of the lower respiratory tract infection (chest infection) was unknown; the patient died due to COVID-19 on 05Jan2021. It was not reported if an autopsy was performed. No follow-up activities are possible. No further information is expected.; Reported Cause(s) of Death: covid 19


VAERS ID: 993420 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2020-12-17
Onset:2020-12-30
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-02-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ0553 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-20
   Days after onset: 21
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Patient has not had symptoms associated with COVID-19 Patient is not enrolled in clinical trial
Allergies:
Diagnostic Lab Data: Test Date: 20201230; Test Name: SARS-CoV-2 test; Test Result: Positive
CDC Split Type: GBPFIZER INC2021077287

Write-up: SARS-CoV-2 infection; SARS-CoV-2 infection; This is a spontaneous report received from a contactable other health professional received from the Regulatory Agency. Regulatory authority report number GB-MHRA-WEBCOVID-202101221748287090, Safety Report Unique Identifier GB-MHRA-ADR 24634241. An 89-year-old female patient received bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech, lot# EJ0553), via an unspecified route of administration, on 17Dec2020, at single dose, for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. Patient has not had symptoms associated with COVID-19 and was not enrolled in clinical trial. The patient experienced SARS-CoV-2 infection on 30Dec2020. The patient underwent lab tests and procedures which included SARS-CoV-2 test: positive on 30Dec2020. The patient died on 20Jan2021 due to SARS-CoV-2 infection. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: SARS-CoV-2 infection


VAERS ID: 993422 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-05
Onset:2021-01-06
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ688 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Blood test, COVID-19, Chest X-ray, Culture, Drug ineffective, Dyspnoea, Immune system disorder, SARS-CoV-2 test
SMQs:, Anaphylactic reaction (broad), Lack of efficacy/effect (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-07
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Endometrial cancer (Figo stage 3c1); Type II diabetes mellitus (Longstanding)
Preexisting Conditions: Medical History/Concurrent Conditions: Ankylosing spondylitis; Cataracts; Chronic kidney disease; Kidney cancer (treated 2006); Kidney stones (Recurrent); Obesity; Uterine cancer; Comments: Unsure if patient has had symptoms associated with COVID-19. Inconclusive test. Patient is not enrolled in clinical trial.
Allergies:
Diagnostic Lab Data: Test Name: Blood test; Result Unstructured Data: Test Result:unknown result; Test Name: Chest X-ray; Result Unstructured Data: Test Result:unknown result; Test Name: Culture; Result Unstructured Data: Test Result:unknown result; Test Date: 20210106; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Inconclusive test
CDC Split Type: GBPFIZER INC2021077178

Write-up: SARS-CoV-2 infection; SARS-CoV-2 infection; Immune imbalance; Shortness of breath; This is a spontaneous report received from a contactable physician by Pfizer from the Medicines and Healthcare products Regulatory Agency (MHRA). The regulatory authority report number is GB-MHRA-WEBCOVID-202101241753594380, Safety Report Unique Identifier GB-MHRA-ADR 24639286. A 65-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EJ688), via an unspecified route of administration on 05Jan2021 at single dose for covid-19 immunisation. Medical history included ongoing endometrial cancer (Figo stage 3c1), uterine cancer (not ongoing), renal cancer (not ongoing) treated 2006, ongoing type 2 diabetes mellitus (longstanding), obesity (unknown if ongoing), chronic kidney (unknown if ongoing), cataract (unknown if ongoing), nephrolithiasis (recurrent, unknown if ongoing) and ankylosing spondylitis (unknown if ongoing). Patient was not enrolled in clinical trial. Concomitant medications were not reported. The patient previously received influenza vaccine (split virion, inactivated) on 01Oct2020 and pneumococcal vaccine polysacch on 03Dec2020 bot for immunization. The patient experienced sars-cov-2 infection, immune imbalance and shortness of breath on 06Jan2021. The patient was admitted to hospital on 06Jan2021 and died on 07Jan2021 due to SARS-CoV-2 infection. It was unsure if patient has had symptoms associated with COVID-19. The patient underwent lab tests and procedures which included blood test, culture and chest x-ray on unknown date with unknown results. The patient ad and inconclusive COVID-19 virus test on 06Jan2021. It was not reported if an autopsy was performed. All the events were considered serious as important medical events and hospitalization. Only sars-cov-2 infection had a fatal outcome. No follow up attempts are possible. No further information is expected.; Reported Cause(s) of Death: SARS-CoV-2 infection


VAERS ID: 994861 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-01
Onset:2020-12-01
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Abdominal adhesions, Biopsy, COVID-19, Chest X-ray, Drug ineffective, Pneumonia aspiration, Postoperative ileus, SARS-CoV-2 test, Small intestinal obstruction, Vomiting
SMQs:, Acute pancreatitis (broad), Lack of efficacy/effect (narrow), Retroperitoneal fibrosis (broad), Gastrointestinal obstruction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2020-12-31
   Days after onset: 30
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: TIMOPTOL; SYSTANE; VITAMIN B12 [VITAMIN B12 NOS]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Duodenal ulcer; Glaucoma; Hemochromatosis; Spinal stenosis; Vitamin B12 deficiency
Allergies:
Diagnostic Lab Data: Test Date: 202012; Test Name: laparotomy samples; Result Unstructured Data: Test Result:unknown results; Test Date: 202012; Test Name: Chest X-ray; Result Unstructured Data: Test Result:features of COVID-19 infection; Test Date: 20201229; Test Name: COVID-19 virus test; Test Result: Positive
CDC Split Type: GBPFIZER INC2021079256

Write-up: Pneumonia aspiration; uncertain if drug related reaction but presented to hospital with small bowel obstruction and also covid positive; uncertain if drug related reaction but presented to hospital with small bowel obstruction and also covid positive; uncertain if drug related reaction but presented to hospital with small bowel obstruction and also covid positive; Abdominal adhesions; Vomiting; Postoperative ileus; This is a spontaneous report received from a contactable physician by Pfizer from the Regulatory Authority. The regulatory authority report number is GB-MHRA-EYC 00236716 and GB-MHRA-ADR 24549472. An 86-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscularly, in Dec2020 (reported as 2 to 3 weeks prior to event) at a single dose for COVID-19 vaccination. Medical history included glaucoma, spinal stenosis, vitamin V12 deficiency, duodenal ulcer, and haemochromatosis. Concomitant medications included timolol maleate (TIMOPTOL), macrogol 400, propylene glycol (SYSTANE), and vitamin B12 (MANUFACTURER UNKNOWN). The patient experienced pneumonia aspiration in Dec2020, which caused hospitalization and was reported as fatal. In Dec2020, it was uncertain if drug related reaction but presented to hospital with small bowel obstruction and also COVID positive and experienced abdominal adhesions, vomiting, and postoperative ileus; all of which caused hospitalization. The clinical course was reported as follows: It was uncertain if drug related reaction but presented to hospital with small bowel obstruction and also COVID positive. Retrospectively, it was ascertained that the patient had recently received coronavirus vaccination in the community hub. The patient presented to the hospital with features of small bowel obstruction, which did not settle with conservative management so taken to theatre. At laparotomy, adhesion was found requiring excision and anastomosis. The samples were sent to pathology with unknown results in Dec2020. The patient did not have an admission swab for COVID-19 as patient refused and then, post-operatively, the patient had a COVID-19 virus test, which was found to be positive on 29Dec2020. It was reported that the time frame suggested community acquired. The patient was reported to have likely developed ileus and vomited, and cause of death was reported as probably aspiration pneumonia. There were some features of COVID-19 infection on chest X-ray in Dec2020, but no large oxygen requirement immediately prior to death. In the hospital, the patient received ondansetron (MANUFACTURER UNKNOWN), paracetamol (MANUFACTURER UNKNOWN), remdesivir (MANUFACTURER UNKNOWN), dexamethasone (MANUFACTURER UNKNOWN), enoxaparin (MANUFACTURER UNKNOWN), benzylpenicillin (MANUFACTURER UNKNOWN), carbocysteine (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), and general anesthetic. No post mortem was performed, however the patient did undergo a laparotomy prior to death. Therapeutic measures were taken as a result of all of the events as aforementioned. The clinical outcome of pneumonia aspiration was fatal and of uncertain if drug related reaction but presented to hospital with small bowel obstruction and also COVID positive, abdominal adhesions, vomiting, and postoperative ileus was unknown. The patient died on 31Dec2020. The cause of death was reported as pneumonia aspiration. An autopsy was not performed. No follow-up attempts are possible, information about batch number cannot be obtained.; Reported Cause(s) of Death: Pneumonia aspiration


VAERS ID: 994885 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-19
Onset:2021-01-01
Submitted: 0000-00-00
Entered: 2021-02-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK4243 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Death, Drug ineffective, Pain in extremity, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Tendinopathies and ligament disorders (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-20
   Days after onset: 19
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: RAMIPRIL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: 2nd degree heart block; Cardiac disorder; Dilatation atrial; Left bundle branch block (Cardiac- LBBB, dilated left ventricle, dilated atrium, dyskinesia septum, 2nd degree heart block); Left ventricular dilatation; Left ventricular hypertrophy; Suspected COVID-19 (Unsure when symptoms started Unsure when symptoms stopped); Comments: Cardiac- LBBB, dilated left ventricle, dilated atrium, dyskinesia septum, 2nd degree heart block Patient is not enrolled in clinical trial
Allergies:
Diagnostic Lab Data: Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Yes - Positive COVID-19 test
CDC Split Type: GBPFIZER INC2021072091

Write-up: Yes- Positive COVID-19 test; Yes- Positive COVID-19 test; Death; sore arm; This is a spontaneous report from a contactable physician. This is a report received from the Regulatory Authority. The Regulatory authority report number is GB-MHRA-WEBCOVID-202101222143440710, Safety Report Unique Identifier GB-MHRA-ADR 24635342. An adult male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number:EK4243, expiry date unspecified), via an unspecified route of administration on 19Jan2021 at a single dose for COVID-19 immunisation. Medical history included suspected covid-19 (unsure when symptoms started, unsure when symptoms stopped), cardiac LBBB (left bundle branch block), dilated left ventricle, dilated atrium, dyskinesia septum, 2nd degree heart block, and left ventricular hypertrophy. Patient was not enrolled in clinical trial. Concomitant medication included ramipril on unspecified date for left ventricular hypertrophy. In the evening of 19Jan2021, the patient volunteered and received the vaccine. Sore arm reported only afterwards on unspecified date in Jan2021. On 20Jan2021, the patient was found dead in bed (death). The patient underwent lab test which included COVID-19 virus test: Yes- positive COVID-19 test on unspecified date. Cause of death was unknown. It was unknown if an autopsy was performed. No follow-up activities are possible. No further information is expected.; Reported Cause(s) of Death: death


VAERS ID: 994886 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-06
Onset:2021-01-06
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, Loss of consciousness, SARS-CoV-2 test
SMQs:, Torsade de pointes/QT prolongation (broad), Lack of efficacy/effect (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-09
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Alzheimer''s disease; Cardiac failure congestive (CCF); Comments: Patient has not had symptoms associated with COVID-19. Patient is not enrolled in clinical trial.
Allergies:
Diagnostic Lab Data: Test Date: 20210106; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Yes - Positive COVID-19 test
CDC Split Type: GBPFIZER INC2021077364

Write-up: Unconscious; positive COVID-19 virus test; SARS-CoV-2 infection; This is a spontaneous report received from a contactable healthcare professional from the regulatory authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202101241937221860 and GB-MHRA-ADR 24639419. A 90-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on 06Jan2021 at a single dose for COVID-19 vaccination. Medical history included dementia Alzheimer''s type and cardiac failure congestive (CCF). The patient did not have symptoms associated with COVID-19. The patient was not enrolled in a clinical trial. The patient''s concomitant medications were not reported. The patient experienced SARS-CoV-2 infection on 06Jan2021, which was reported as fatal. The patient experienced positive COVID-19 virus test on 06Jan2021 and unconscious on 07Jan2021. The patient underwent lab tests and procedures which included COVID-19 virus test: yes - positive COVID-19 test on 06Jan2021. The clinical outcome of positive COVID-19 virus test and SARS-CoV-2 infection was fatal and of unconscious was not recovered. The patient died on 09Jan2021. The cause of death was reported as SARS-CoV-2 infection. It was not reported if an autopsy was performed. No follow up attempts are possible; information about batch number cannot be obtained.; Reported Cause(s) of Death: SARS-CoV-2 infection


VAERS ID: 996674 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-07
Onset:2021-01-08
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ05536450 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, COVID-19, Drug ineffective, Dysstasia, Feeling abnormal, Pyrexia, SARS-CoV-2 test, Skin discolouration, Tremor
SMQs:, Lack of efficacy/effect (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-20
   Days after onset: 12
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Dementia with Lewy bodies; Non-smoker (Never smoked.)
Allergies:
Diagnostic Lab Data: Test Date: 20210108; Test Name: temperature; Result Unstructured Data: Test Result:High; Test Date: 20210120; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Yes - Positive COVID-19 test
CDC Split Type: GBPFIZER INC2021077136

Write-up: SARS-CoV-2 infection; SARS-CoV-2 infection; High temperature; Dysstasia; Skin discolouration; Tremor; Feeling abnormal; This is a spontaneous report received from a contactable consumer. This is a report received from the Regulatory Authority. Regulatory authority report number GB-MHRA-WEBCOVID-202101241732075000, Safety Report Unique Identifier GB-MHRA-ADR 24639306. An 86-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Lot EJ05536450, via an unspecified route of administration on 07Jan2021 at single dose for covid-19 immunisation. The patient previously received the firs dose of BNT162B2 on unspecified date with no adverse events. Medical history included non-tobacco user (Never smoked), dementia with Lewy bodies. The patient''s concomitant medications were not reported. No physical illnesses. Unsure if patient has had symptoms associated with COVID-19. Patient was not enrolled in clinical trial. On 08Jan2021 the patient experienced high temperature, dysstasia, skin discolouration, tremor, feeling abnormal: the patient could not stand up from his bed, he was grey in skin colour, shaking and he said he felt terrible. The patient did not go to hospital and was stabilized with oxygen mask. The events were non serious with outcome of not recovered. On 08Jan2021 the patient experienced SARS-CoV-2 infection. The patient underwent lab tests and procedures which included COVID-19 virus test: yes - positive covid-19 test on 20Jan2021. The event SARS-CoV-2 infection was fatal, and the patient died for SARS-CoV-2 infection on 20Jan2021 at 7.05am. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: SARS-CoV-2 infection


VAERS ID: 1000275 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-14
Onset:2021-01-18
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM0477 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Balance disorder, COVID-19, Cardiac arrest, Computerised tomogram abnormal, Cough, Death, Echocardiogram, Ejection fraction decreased, Gait disturbance, Intracardiac thrombus, Loss of consciousness, Productive cough, Rhinorrhoea, SARS-CoV-2 test positive, Somnolence
SMQs:, Torsade de pointes/QT prolongation (broad), Cardiac failure (narrow), Anaphylactic reaction (narrow), Peripheral neuropathy (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Dementia (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Parkinson-like events (broad), Acute central respiratory depression (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (narrow), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Respiratory failure (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-20
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: SERESTA; ATORVASTATINE ARROW; INNOHEP; ENALAPRIL EG; PHOSPHONEUROS; BISOPROLOL SANDOZ; PANTOPRAZOLE MYLAN; DEXAMETHASONE; JANUVIA [SITAGLIPTIN]; AUGMENTIN [AMOXICILLIN;CLAVULANATE POTASSIUM]; MIMPARA; ELIQUIS; LERCAPRESS [ENALAPRIL MALEATE;
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Acoustic neuroma (Right acoustic neuroma operated on in 2014 with sequelae facial palsy); Adenocarcinoma of colon stage III (Stage IIIB colon adenocarcinoma treated with simplified LV5FU2); AFib (ACFA (complete arrhythmia by atrial fibrillation)); Cerebral thrombosis (hospitalized on 17Dec2020 left hemicorporeal deficit and dysarthria); Dyslipidaemia; Facial palsy (Right acoustic neuroma operated on in 2014 with sequelae facial palsy); Fall (was hospitalized on 17Dec2020); Hospitalisation (improved neurologically,partial regression,total regression-visual impairment,dysarthria); Hospitalization (G1 asthenia throughout the intercure, improvement in BP, better general condition.); Hospitalization; Hypercalcemia (prompting the administration of Pamidronate); Hypertension arterial (HTA (arterial hypertension)); Hypothyroidism; Ileostomy; Iodine allergy; Non-insulin-dependent diabetes mellitus; Obstructive pyelonephritis (Obstructive pyelonephritis in renal colic); Recto-sigmoidectomy; Stroke (hospitalized on 17Dec2020 left hemicorporeal deficit and dysarthria); Surgery (Right acoustic neuroma operated on in 2014 with sequelae facial palsy)
Allergies:
Diagnostic Lab Data: Test Date: 20210119; Test Name: cardio level/Auscultation; Result Unstructured Data: Test Result:no palpitation, no sign of HF, or sign of DVT, reg; Comments: no palpitation, no sign of HF, or sign of DVT, regular auscultation without noticeable breath.; Test Date: 20210120; Test Name: cardio level/Auscultation; Result Unstructured Data: Test Result:Auscultation with the same anomalies as yesterday; Comments: Auscultation with the same anomalies as yesterday (clear drop in MV in left base) therefore monitoring.; Test Date: 20201214; Test Name: BP; Result Unstructured Data: Test Result:117/70 mmHg; Test Date: 20210118; Test Name: BP; Result Unstructured Data: Test Result:106/67 mmHg; Test Date: 20210119; Test Name: BP; Result Unstructured Data: Test Result:140/70 mmHg; Test Date: 20210112; Test Name: orthostatic hypotension test; Test Result: Positive ; Test Date: 20201214; Test Name: afebrile; Result Unstructured Data: Test Result:afebrile; Test Date: 20210118; Test Name: afebrile; Result Unstructured Data: Test Result:afebrile; Test Date: 20210119; Test Name: CT scan; Result Unstructured Data: Test Result:compatible with covid 19 infection (minimal degree; Comments: compatible with covid 19 infection (minimal degree of involvement <10%).; Test Date: 20201214; Test Name: HR; Result Unstructured Data: Test Result:102; Comments: 102 bpm; Test Date: 20210118; Test Name: HR; Result Unstructured Data: Test Result:89; Comments: 89 bpm; Test Date: 20210119; Test Name: pulse; Result Unstructured Data: Test Result:60; Comments: 60 / min; Test Date: 20210114; Test Name: Bubble test; Result Unstructured Data: Test Result:No patent foramen ovale found; Test Date: 20201217; Test Name: MRI; Result Unstructured Data: Test Result:reveals an ischemic stroke of the posterior arm of; Comments: reveals an ischemic stroke of the posterior arm of the right internal capsule and of the diffusing right internal and occipital temporal cortex. On the TOF, we find an occlusion of the posterior cerebral artery from the beginning and an occlusion of the right internal carotid artery with slow cerebral artery and permeable middle cerebral artery.; Test Date: 20201221; Test Name: MRI; Result Unstructured Data: Test Result:Ischemic stroke made up of the right posterior sup; Comments: Ischemic stroke made up of the right posterior superficial Sylvian territory and the superficial and deep territories of the right posterior cerebral artery. Recanalization of the right internal carotid artery and the right posterior cerebral artery of fetal origin.; Test Date: 20201230; Test Name: on the control hepatic MRI; Result Unstructured Data: Test Result:Exploration of an adrenal adenoma accidentally dis; Comments: Exploration of an adrenal adenoma accidentally discovered.; Test Date: 20201224; Test Name: NIHSS score; Result Unstructured Data: Test Result:2; Comments: NIHSS score of 2, with a slight drop in her left upper limb before 10 seconds, and sensitive extinction. There persist ataxia of the lower limbs and facial paralysis which were sequelae respectively of an old cerebellar lesion and a neuroma.; Test Date: 20201214; Test Name: AA saturation; Test Result: 97 %; Test Date: 20210118; Test Name: AA saturation; Test Result: 97 %; Test Date: 20201214; Test Name: clinical examination; Result Unstructured Data: Test Result:normal; Test Date: 20210118; Test Name: clinical examination; Result Unstructured Data: Test Result:Consciousness normal, higher functions a little sl; Comments: Consciousness normal, higher functions a little slowed down and tendency to drowsiness. Staggering walk with loss of balance, must hold on to furniture.; Test Date: 20210119; Test Name: digestive level; Result Unstructured Data: Test Result:no diarrhea, no nausea or vomiting, no abdominal p; Comments: no diarrhea, no nausea or vomiting, no abdominal pain, palpation within the standards; Test Date: 20201214; Test Name: WHO; Result Unstructured Data: Test Result:1-2; Test Date: 20210118; Test Name: WHO; Result Unstructured Data: Test Result:3; Comments: 3 with above all significant loss of autonomy; Test Date: 20210119; Test Name: respiratory level; Result Unstructured Data: Test Result:FR at 15 / min; Comments: respiratory level: FR at 15 / min, Rhinorrhea, expectorating cough, no dyspnea, no chest pain, no anosmia or ageusia, asthenia, no headache auscultation with clear reduction of MV on the left base, elimination of vibrations and dullness; Test Date: 20210120; Test Name: respiratory level; Result Unstructured Data: Test Result:FR at 22 / min, no anosmia or ageusia, no diarrhea; Comments: FR at 22 / min, no anosmia or ageusia, no diarrhea, no dyspnea, no chest pain, no sign of cardiac insufficiency no sign of DVT or VTE.; Test Date: 20210118; Test Name: COVID-19 PCR test; Test Result: Positive ; Test Date: 20201218; Test Name: EDTSA; Result Unstructured Data: Test Result:with an obliteration of the right internal carotid; Comments: with an obliteration of the right internal carotid artery downstream of the portion visualized (which is difficult to assert because on indirect arguments), with good replacement of the cerebral arteries via the anterior communicating artery or with a stenosis of the right siphon without occlusion of the internal carotid artery explaining the velocities preserved in right MCA.; Test Date: 20210114; Test Name: transthoracic ultrasound; Result Unstructured Data: Test Result:LVEF conserved at 50% in SB on an enlarged LV (SIV; Comments: LVEF conserved at 50% in SB on an enlarged LV (SIV and PP 11mm) not dilated. Bi-atrial expansion with left atrium 86 ml / m? and right atrium 21 cm?. No increase in left ventricle filling pressures. Central minimal mitral insuffisiency. Tricuspid aortic valve, mean gradient 2 mmHg. Moderately impaired RV function, no PH with PAPS estimated at 30-35 mmHg. Breathable dilated IVC. Free pericardium. Transesophageal echocardiography: Left auricle not free with impaired emptying rate, no thrombus directly visualized but significant spontaneous contrast.; Test Date: 20201214; Test Name: Weight; Test Result: 62 kg; Test Date: 20210118; Test Name: Weight; Test Result: 60 kg
CDC Split Type: FRPFIZER INC2021088311

Write-up: Death unexplained/massive pulmonary embolism in the context of neoplastic COVID +; Massive stroke related to intracardiac thrombus; massive pulmonary embolism in the context of neoplastic COVID +/Covid19 PCR performed: positive/CT scan compatible with covid 19 infection; massive pulmonary embolism in the context of neoplastic COVID +/Covid19 PCR performed: positive/CT scan compatible with covid 19 infection; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) -WEB, FR-AFSSAPS-DJ20210104. A 75-year-old female patient received bnt162b2 (COMIRNATY, lot number: EM0477), via intramuscular on 14Jan2021 at single dose for COVID-19 vaccination. Medical history included stage IIIB colon adenocarcinoma- (pT3N1aM0) from Aug2020 and unknown if it was ongoing with rectosigmoid resection on 27Aug2020 and ileostomy closure on 09Oct2020. HTA (arterial hypertension), ACFA (complete arrhythmia by atrial fibrillation), Non-insulin-dependant diabetes, Dyslipidemia, Obstructive pyelonephritis in renal colic, Hypothyroidism, right acoustic neuroma (operated on in 2014 with sequelae facial palsy), and all unknown if they were ongoing and notion of allergy to iodine. The patient followed in particular for an adenocarcinoma of the colon treated with simplified LV5FU2 (cisplatin, 5-fluorouracil, leucovorin) as an adjuvant with a 4th treatment carried out in a day hospital on 14Dec2020. The patient is non-DPD deficient. The patient lives at home with her husband, a household helper, a nurse who comes several times a week. Autonomous for toilet and meals. The report of the day hospitalization of 14Dec2020 mentioned: INTERCURE: G1 asthenia throughout the intercure, improvement in BP, better general condition. CLINICAL REVIEW: WHO 1-2, BP 117/70 mmHg, HR 102 bpm, afebrile, 97% AA saturation. Weight 62 kg stable. Normal clinical examination. She received her cure of LV5FU2. She was hospitalized on 17Dec2020 for a stroke in the territory of the right posterior cerebral artery, with thrombus in P1, not revascularized (fall from her bed at 6 a.m., her husband noting a left hemicorporeal deficit and dysarthria). An MRI is immediately performed which reveals an ischemic stroke of the posterior arm of the right internal capsule and of the diffusing right internal and occipital temporal cortex. On the TOF, we find an occlusion of the posterior cerebral artery from the beginning and an occlusion of the right internal carotid artery with slow cerebral artery and permeable middle cerebral artery. EDTSA carried out on 18Dec2020: "The echo-Doppler anomalies presented can be compatible either: with an obliteration of the right internal carotid artery downstream of the portion visualized by echo-Doppler (which is difficult to assert because on indirect arguments), if this is the case, it looks old since ''''with good replacement of the cerebral arteries via the anterior communicating artery or with a stenosis of the right siphon without occlusion of the internal carotid artery explaining the velocities preserved in right MCA". Cerebral MRI of 21Dec2020: Ischemic stroke made up of the right posterior superficial Sylvian territory and the superficial and deep territories of the right posterior cerebral artery. Recanalization of the right internal carotid artery and the right posterior cerebral artery of fetal origin. During the stay, she improved neurologically, with partial regression of motor impairment, total regression of visual impairment and dysarthria. Upon discharge, she presented a NIHSS score of 2, with a slight drop in her left upper limb before 10 seconds, and sensitive extinction. There persist ataxia of the lower limbs and facial paralysis which were sequelae respectively of an old cerebellar lesion and a neuroma. The patient is anticoagulated by LMWH tinzaparin sodium (INNOHEP), due to the occurrence of a stroke under ELIQUIS, her known AF, and the neoplastic context. INNOHEP will be continued in the long term. She was leaving for her home on 24Dec2020. Patient finally admitted to Follow-up and Rehabilitation Care on 30Dec2020. Decision with the patient not to resume adjuvant chemotherapy given the loss of autonomy and an unfavorable benefit-risk balance. Similarly contraindication to any colonoscopy. Exploration of an adrenal adenoma accidentally discovered on the control hepatic MRI. Hypercalcemia on 31Dec2020 prompting the administration of Pamidronate. On 12Jan2021: Positive orthostatic hypotension test. Concomitant medications included oxazepam (SERESTA) from Dec2020, atorvastatin calcium (ATORVASTATINE ARROW), tinzaparin sodium (INNOHEP) from 22Dec2020 for Atrial fibrillation, enalapril maleate (ENALAPRIL EG), calcium phosphate monobasic, magnesium glycerophosphate, phosphoric acid, sodium phosphate dibasic (PHOSPHONEUROS) from 19Jan2021, bisoprolol fumarate (BISOPROLOL SANDOZ), pantoprazole sodium sesquihydrate (PANTOPRAZOLE MYLAN) from Dec2020, dexamethasone from 19Jan2021, sitagliptin (JANUVIA), amoxicillin, clavulanate potassium (AUGMENTIN) from 19Jan2021, cinacalcet hydrochloride (MIMPARA) from 12Jan2021, apixaban (ELIQUIS), enalapril maleate, lercanidipine hydrochloride (LERCAPRESS), esomeprazole, macrogol 3350, potassium chloride, sodium bicarbonate, sodium chloride (MOVICOL), alprazolam. Notification from a hospital specialist concerning this patient who died as a result of vaccination with COMIRNATY. Vaccination by COMIRNATY on 14Jan2021 with good immediate tolerance. The same day realization of a transthoracic ultrasound which was programmed: LVEF conserved at 50% in SB on an enlarged LV (SIV and PP 11mm) not dilated. Bi-atrial expansion with left atrium 86 ml / m? and right atrium 21 cm?. No increase in left ventricle filling pressures. Central minimal mitral insuffisiency. Tricuspid aortic valve, mean gradient 2 mmHg. Moderately impaired RV function, no PH with PAPS estimated at 30-35 mmHg. Breathable dilated IVC. Free pericardium. Transesophageal echocardiography: Left auricle not free with impaired emptying rate, no thrombus directly visualized but significant spontaneous contrast. Bubble test: No patent foramen ovale found. On 15Jan2021: Well clinically. No headache, no cough, no transit disorder following the Covid vaccination. Good constants, afebrile. On 16Jan2021: Appearance of a cough. She was reviewed in hospitalization oncology day on 18Jan2021 for reassessment. CLINICAL EXAMINATION: WHO 3 with above all significant loss of autonomy. Consciousness normal, higher functions a little slowed down and tendency to drowsiness. BP 106/67 mmHg, HR 89 bpm, afebrile, 97% AA saturation. Weight 60 kg (-2 kg). Staggering walk with loss of balance, must hold on to furniture. On 18Jan2021: No fever, no diarrhea, no other symptom found apart from the cough. Covid19 PCR performed: positive. On 19Jan2021: blood pressure 140/70 mmHg, pulse 60 / min, respiratory level: FR at 15 / min, Rhinorrhea, expectorating cough, no dyspnea, no chest pain, no anosmia or ageusia, asthenia, no headache auscultation with clear reduction of MV on the left base, elimination of vibrations and dullness therefore: possible pleural effusion. At the cardio level: no palpitation, no sign of HF, or sign of DVT, regular auscultation without noticeable breath. At the digestive level: no diarrhea, no nausea or vomiting, no abdominal pain, palpation within the standards. Note that the patient does not want to go to intensive care in the event of deterioration, she does not want intubation. At the end of the morning, episode of loss of contact with return to full consciousness for several minutes, it is possible that she was suffering from epilepsy after his stroke with lowering of the epileptogenic threshold on COVID / fever. No brain imaging. On the other hand, in view of the saturation: initiation of dexamethasone and AUGMENTIN + realization of an emergency chest scanner today (on 19Jan2021). CT scan compatible with covid 19 infection (minimal degree of involvement <10%). On 20Jan2021 at 11:30 am the consultation word mentions: better today, FR at 22 / min, no anosmia or ageusia, no diarrhea, no dyspnea, no chest pain, no sign of cardiac insufficiency no sign of DVT or VTE. Auscultation with the same anomalies as yesterday (clear drop in MV in left base) therefore monitoring. The same day on 20Jan2021, call from a licensed nurse around 2:35 p.m. for a patient found on the ground, not reactive. Arrival of the doctor in the room: patient in a state of clinical death, facial cyanosis, no pulse, no breathing, no heart rate. Total asystole. Time of death recorded 14:45. Most likely in no flow for 15 minutes. Patient who had refused resuscitation care yesterday in the event of degradation (refusal of CPR and intubation) so in this context no resuscitation procedure started. Opinion of the doctor in charge of the patient since entry into Follow-up and Rehabilitation Care: presence of an intracardiac thrombus with great certainty according to cardiologists. Possible cause of death: massive pulmonary embolism in the context of neoplastic COVID +, Massive stroke related to intracardiac thrombus. Exclusive role of COVID (see respiratory distress) very unlikely because no major respiratory damage in this patient, correct respiratory rate and saturation. AF was fairly stable (no recent ECG either). Unexplained death notified because the participatory role of the vaccine cannot be completely excluded. The patient died on 20Jan2021. An autopsy was not performed. No follow-up attempts are possible, no information is expected.; Reported Cause(s) of Death: massive pulmonary embolism in the context of neoplastic COVID +; Massive stroke related to intracardiac thrombus; Massive stroke related to intracardiac thrombus; massive pulmonary embolism in the context of neoplastic COVID +; massive pulmonary embo


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=6&ESORT=AGE&SYMPTOMS=COVID-19&VAX=COVID19&DIED=Yes

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166